BNGO
Price
$4.25
Change
+$0.15 (+3.66%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
57.43M
SONVY
Price
$58.18
Change
-$0.07 (-0.12%)
Updated
Apr 23 closing price
Capitalization
16.61B
Ad is loading...

BNGO vs SONVY

Header iconBNGO vs SONVY Comparison
Open Charts BNGO vs SONVYBanner chart's image
Bionano Genomics
Price$4.25
Change+$0.15 (+3.66%)
Volume$1K
Capitalization57.43M
Sonova Holding AG
Price$58.18
Change-$0.07 (-0.12%)
Volume$24.56K
Capitalization16.61B
BNGO vs SONVY Comparison Chart
Loading...
BNGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SONVY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BNGO vs. SONVY commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNGO is a Hold and SONVY is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (BNGO: $4.10 vs. SONVY: $58.18)
Brand notoriety: BNGO and SONVY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BNGO: 62% vs. SONVY: 96%
Market capitalization -- BNGO: $57.43M vs. SONVY: $16.61B
BNGO [@Medical Specialties] is valued at $57.43M. SONVY’s [@Medical Specialties] market capitalization is $16.61B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BNGO’s FA Score shows that 1 FA rating(s) are green whileSONVY’s FA Score has 1 green FA rating(s).

  • BNGO’s FA Score: 1 green, 4 red.
  • SONVY’s FA Score: 1 green, 4 red.
According to our system of comparison, SONVY is a better buy in the long-term than BNGO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BNGO’s TA Score shows that 4 TA indicator(s) are bullish while SONVY’s TA Score has 5 bullish TA indicator(s).

  • BNGO’s TA Score: 4 bullish, 5 bearish.
  • SONVY’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SONVY is a better buy in the short-term than BNGO.

Price Growth

BNGO (@Medical Specialties) experienced а +1.23% price change this week, while SONVY (@Medical Specialties) price change was +2.76% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +4.26%. For the same industry, the average monthly price growth was -6.64%, and the average quarterly price growth was -2.53%.

Reported Earning Dates

BNGO is expected to report earnings on Mar 31, 2025.

SONVY is expected to report earnings on Nov 19, 2024.

Industries' Descriptions

@Medical Specialties (+4.26% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SONVY($16.6B) has a higher market cap than BNGO($57.4M). SONVY YTD gains are higher at: -10.547 vs. BNGO (-76.306). SONVY has higher annual earnings (EBITDA): 979M vs. BNGO (-213.4M). SONVY has higher revenues than BNGO: SONVY (3.74B) vs BNGO (36.1M).
BNGOSONVYBNGO / SONVY
Capitalization57.4M16.6B0%
EBITDA-213.4M979M-22%
Gain YTD-76.306-10.547723%
P/E RatioN/A22.22-
Revenue36.1M3.74B1%
Total Cash102MN/A-
Total Debt79.4MN/A-
FUNDAMENTALS RATINGS
BNGO vs SONVY: Fundamental Ratings
BNGO
SONVY
OUTLOOK RATING
1..100
2220
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
12
Undervalued
PROFIT vs RISK RATING
1..100
10053
SMR RATING
1..100
9691
PRICE GROWTH RATING
1..100
6560
P/E GROWTH RATING
1..100
8645
SEASONALITY SCORE
1..100
n/a39

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SONVY's Valuation (12) in the null industry is in the same range as BNGO (25) in the Biotechnology industry. This means that SONVY’s stock grew similarly to BNGO’s over the last 12 months.

SONVY's Profit vs Risk Rating (53) in the null industry is somewhat better than the same rating for BNGO (100) in the Biotechnology industry. This means that SONVY’s stock grew somewhat faster than BNGO’s over the last 12 months.

SONVY's SMR Rating (91) in the null industry is in the same range as BNGO (96) in the Biotechnology industry. This means that SONVY’s stock grew similarly to BNGO’s over the last 12 months.

SONVY's Price Growth Rating (60) in the null industry is in the same range as BNGO (65) in the Biotechnology industry. This means that SONVY’s stock grew similarly to BNGO’s over the last 12 months.

SONVY's P/E Growth Rating (45) in the null industry is somewhat better than the same rating for BNGO (86) in the Biotechnology industry. This means that SONVY’s stock grew somewhat faster than BNGO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BNGOSONVY
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
47%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
67%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
67%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
52%
Advances
ODDS (%)
Bullish Trend 11 days ago
79%
Bullish Trend 14 days ago
66%
Declines
ODDS (%)
Bearish Trend 9 days ago
89%
Bearish Trend 9 days ago
55%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
64%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
57%
View a ticker or compare two or three
Ad is loading...
BNGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SONVY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TWEBX17.30N/A
N/A
Tweedy, Browne Value
WFINX48.07N/A
N/A
Allspring Index C
RTNSX11.91N/A
N/A
Russell Inv Tax-Managed Intl Eq S
CIGYX10.70N/A
N/A
AB Concentrated International Growth Adv
MSVOX5.26N/A
N/A
Morgan Stanley Vitality Portfolio R6

SONVY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SONVY has been loosely correlated with ALC. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if SONVY jumps, then ALC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SONVY
1D Price
Change %
SONVY100%
-0.12%
ALC - SONVY
51%
Loosely correlated
+0.42%
SAUHY - SONVY
48%
Loosely correlated
+0.49%
AORT - SONVY
42%
Loosely correlated
+2.19%
SNN - SONVY
40%
Loosely correlated
+1.38%
OFIX - SONVY
39%
Loosely correlated
+2.13%
More